Welcome to the Longevity Therapeutics Summit – Home to The Ambitious Quest to Cure Age-Related Diseases & Ultimately Aging

The pursuit for the first approved longevity drug to treat the mechanisms of aging has never been more exciting with our understanding of the underlying biology of aging evolving and many innovative therapeutic options making significant preclinical and clinical progress.

The unmissable Longevity Therapeutics Summit is the only industry-led meeting uniting 100+ leading biotech/pharma drug developers, pioneering academics, and prominent investors striving to develop effective, novel anti-aging drugs and overcome major preclinical, translational, clinical, and regulatory obstacles.

This is your must-attend meeting to reunite with your peers in the longevity field and share your ideas and opinions.

2022 Speakers Included:

Viktoria Kheifets

Senior Vice President

Alkahest

Michael Fossel

President

Telocyte

Louis Hawthorne

Chief Executive Officer

NaNotics

Erin Kimbrel

VP, Research

Astellas Institute for Regenerative Medicine

Kate Batz

Managing Partner

Deep Knowledge Group

Nir Barzilai

Director

The Institute for Aging Research at the Albert Einstein College of Medicine

Robin Mansukhani

Chief Executive Officer

Deciduous Therapeutics

Erik Stoops

Head of Development

ADx NeuroSciences

Previous Attending Companies Include

Proud to Partner With: